ClinicalTrials.gov
public full text
Public Domain
MRI in Staging Ovarian Cancer Using MRI Contrast Agent
Can MRI be used to stage ovarian cancer?
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Total Neoadjuvant mFOLFOX6 Plus Suvemcitug and Enlonstobart With Selective Omission of Pelvic Radiotherapy for High-Risk Mid-Rectal Locally Advanced Rectal Cancer#982188
- MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer#895445
- Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer#869427
- Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy#981885
- Magnetite nanodiscs as vortex-enhanced MRI contrast agents: a novel approach in medical imaging.#156916
Record · ID 897705
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive